These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 17704746
1. Serum levels of sFas and sFasL during chemotherapy of lung cancer. Naumnik W, Izycki T, Ossolinska M, Chyczewska E. Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746 [Abstract] [Full Text] [Related]
2. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B. Rocz Akad Med Bialymst; 2004 Jun; 49():246-51. PubMed ID: 15631351 [Abstract] [Full Text] [Related]
3. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy. Izycki T, Chyczewska E, Naumnik W, Talalaj J, Panek B, Ossolinska M. Exp Oncol; 2004 Dec; 26(4):316-9. PubMed ID: 15627066 [Abstract] [Full Text] [Related]
6. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Naumnik W, Izycki T, Swidzińska E, Ossolińiska M, Chyczewska E. Oncol Res; 2007 Oct; 16(9):445-51. PubMed ID: 18074680 [Abstract] [Full Text] [Related]
8. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2. Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S. J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337 [Abstract] [Full Text] [Related]
9. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Shimizu M, Kondo M, Ito Y, Kume H, Suzuki R, Yamaki K. Cancer Detect Prev; 2005 Nov; 29(2):175-80. PubMed ID: 15829378 [Abstract] [Full Text] [Related]
13. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF. Onalan G, Selam B, Baran Y, Cincik M, Onalan R, Gündüz U, Ural AU, Pabuccu R. Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917 [Abstract] [Full Text] [Related]
14. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment. Pignataro L, Arisi E, Sambataro G, Corsi MM. J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205 [Abstract] [Full Text] [Related]
15. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL. Jabłońska E, Kiersnowska-Rogowska B, Rogowski F, Parfieńczyk A, Puzewska W, Bukin M. Rocz Akad Med Bialymst; 2005 Jun; 50():204-7. PubMed ID: 16358967 [Abstract] [Full Text] [Related]
17. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. Song le H, Binh VQ, Duy DN, Bock TC, Kremsner PG, Luty AJ, Mavoungou E. J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799 [Abstract] [Full Text] [Related]